Full-Time

Director of Apheresis

Cell and Gene Therapies

Posted on 11/19/2024

DaVita

DaVita

10,001+ employees

Provides comprehensive kidney care services

Healthcare

Compensation Overview

$133.3k - $195.7kAnnually

Senior, Expert

Denver, CO, USA

The job is associated with the Denver headquarters, indicating a hybrid work model.

Category
Healthcare Administration & Support
Medical, Clinical & Veterinary
Required Skills
Customer Service

You match the following DaVita's candidate preferences

Employers are more likely to interview you if you match these preferences:

Degree
Experience
Requirements
  • Significant apheresis experience with clinical understanding of apheresis therapy types and clinical indications
  • Strong understanding of gene and cell therapy trends and how the apheresis market is changing
  • Clinical background preferred, but not required
  • Knowledge of FACT accreditation preferred
  • Bachelors Degree required
  • Masters Degree Preferred
Responsibilities
  • Responsible for growth and support of Apheresis service line within DaVita’s Hospital Services Group
  • Develop plans to achieve DaVita’s objectives related to revenue, EBITDA, presence, etc.
  • Supports business development and clinical teammates in customer conversations as an apheresis service line expert
  • Partners with outside vendors, DaVita’s Corporate Development, field teammates, and DaVita’s Hospital Services Group team to identify opportunities to serve new customers or add therapies to current customers
  • Monitors new therapy developments (e.g., CAR-T) and existing therapy innovation (e.g., gene and cell therapy use cases)
  • Develops new messaging and communication in partnership with DaVita’s Hospital Services Group, Clinical Education
  • Works directly with clinical leaders and DaVita’s Hospital Services Group on apheresis Pro Formas and pricing strategies
  • Works with DaVita’s Hospital Services Group and field teams to standardize go-live processes and approve program starts
  • Maintains awareness of regulations pertaining to apheresis and cell collection and ensures compliance in program development
Desired Qualifications
  • Experience growing product lines
  • Expertise in apheresis market trends
  • Experience working for an existing apheresis program for an AMC or system
  • Experience working for a machine manufacturer (e.g., Terumo)
  • Experience working for an association or accreditation agency (e.g., FACT)

DaVita provides specialized kidney care services for patients with chronic kidney disease (CKD) and end-stage renal disease (ESRD). The company operates a network of dialysis centers where patients receive treatment, along with offering educational resources and dietary guidance to help manage their kidney health. DaVita's approach is centered around value-based care, which means they focus on improving patient outcomes while also aiming to reduce healthcare costs. They use clinical metrics to monitor and enhance the effectiveness of their treatments. Unlike many competitors, DaVita emphasizes a holistic and equitable approach to care, striving to create a supportive healthcare community. The goal of DaVita is to transform kidney care and ensure that patients receive comprehensive and proactive support.

Company Size

10,001+

Company Stage

IPO

Total Funding

N/A

Headquarters

Denver, Colorado

Founded

1979

Simplify Jobs

Simplify's Take

What believers are saying

  • Telehealth expansion can improve patient access and chronic disease management for DaVita.
  • Wearable health technology integration can enhance patient monitoring and engagement for DaVita.
  • AI utilization can improve clinical outcomes and operational efficiency in DaVita's dialysis centers.

What critics are saying

  • Emerging competition from biotechnology companies could disrupt DaVita's dialysis-focused model.
  • New leadership appointments may lead to strategic shifts impacting company stability.
  • Expansion into new facilities could strain financial resources if not managed effectively.

What makes DaVita unique

  • DaVita focuses on comprehensive kidney care, including dialysis and patient education.
  • The company leverages clinical metrics to enhance treatment efficacy and patient outcomes.
  • DaVita offers integrated care programs to reduce healthcare costs and improve patient quality of life.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

401(k) Company Match

Paid Vacation

Family Planning Benefits

Professional Development Budget

Mental Health Support

Pet Insurance

Company News

PR Newswire
Jan 15th, 2025
Davita Celebrates 25 Years Of Exceptional Patient Care, Empowering The Future Of Kidney Health

DENVER, Jan. 15, 2025 /PRNewswire/ -- DaVita, a comprehensive kidney care provider, is celebrating 25 years of clinical care delivery and leadership in healthcare innovation. Since forming with a purpose "to give life" in 2000, DaVita has focused its efforts to improve clinical outcomes, enhance quality of life for patients and be a force for positive change for the healthcare system. By fostering an inclusive, mission-driven workforce and building strong community partnerships, DaVita is helping empower the future of kidney health

Hispanic Today
Jan 9th, 2025
Patient Care Technician

To help advance your career, DaVita launched Clinical Ladders for PCTs.

Black Perspective
Dec 29th, 2024
Manager, DaVita Venture Group

DVG leverages a mix of venture investment, acquisition, and partnership strategies to develop products and services that improve care for patients suffering from kidney disease and related comorbidities.

Intelligence360
Dec 18th, 2024
Davita To Spend $1,500,000.00 To Occupy 8,736 Square Feet Of Space In Pearland Texas.

DaVita to spend $1,500,000.00 to occupy 8,736 square feet of space in Pearland Texas. DaVita to spend $1,500,000.00 to occupy 8,736 square feet of space in Pearland Texas.Pearland, Texas — According to state and local development sources, DaVita plans to invest $1,500,000.00 to build out 8,736 square feet of new space in Pearland. The company plans to occupy the new space at 9223 W. Broadway Suite 109 in Pearland, on or about August 1, 2025. According to the company website The name DaVita is an adaptation of an Italian phrase meaning giving life. We give life every day in our clinics to patients needing dialysis

PR Newswire
Nov 8th, 2024
Davita Inc. To Participate In Ubs Global Healthcare Conference 2024

DENVER, Nov. 8, 2024 /PRNewswire/ -- DaVita Inc. (NYSE: DVA) today announced that its chief financial officer, Joel Ackerman, and its group vice president of investor relations, Nic Eliason, will participate in a fireside chat with investors at UBS Global Healthcare Conference 2024 on Tuesday, November 12, 2024 at 12:30 pm PST (3:30 pm EST). To view the live webcast, visit the UBS page here and create a free registration. About DaVita Inc

INACTIVE